文献速递呼吸危重症与机械通气

低氧血症严重程度与高频振荡通气在ARDS中的疗效

Severity of Hypoxemia and Effect of High-Frequency Oscillatory Ventilation in Acute Respiratory Distress Syndrome.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01

该个体患者数据荟萃分析纳入4项随机试验共1552例成人ARDS患者,比较高频振荡通气(HFOV)与常规通气。30天死亡率HFOV组40.9%对对照组37.6%(校正OR 1.17,95%CI 0.94-1.46,P=0.16),但疗效随基线低氧血症严重程度而异(P=0.0003),HFOV增加气压伤风险。

要点

  • HFOV总体未显著降低ARDS患者30天死亡率,且增加气压伤风险。
  • 疗效随基线低氧血症严重程度改变,轻中度ARDS可能有害。
  • 极重度低氧血症患者接受HFOV可能存在生存获益。

核心结论

  • HFOV增加多数ARDS患者死亡率,但可能改善常规机械通气下严重低氧血症患者的生存。

研究设计与样本

  • 个体患者数据荟萃分析,纳入4项比较HFOV与常规通气治疗成人ARDS的随机试验,共1552例患者。
  • 采用多变量分层logistic回归模型检验预设效应修饰因素,校正重要预后因素和聚类效应。

主要发现

  • 30天死亡率HFOV组为321/785(40.9%),对照组为288/767(37.6%),校正OR 1.17(95%CI 0.94-1.46,P=0.16)。
  • 治疗效应随基线低氧血症严重程度变化(P=0.0003),轻中度ARDS患者随PaO2/FiO2升高 harm 增加,极重度ARDS患者死亡风险可能降低。
  • HFOV相比常规通气增加气压伤风险,校正OR 1.75(95%CI 1.04-2.96,P=0.04)。
  • 基线平均PaO2/FiO2为114±39 mm Hg,40%为重度ARDS(PaO2/FiO2<100 mm Hg)。
  • 肺顺应性和体重指数未修饰治疗效应。

关键数值与推荐

  • 重度ARDS定义:PaO2/FiO2<100 mm Hg。
  • 30天死亡率:HFOV组40.9%,对照组37.6%。
  • 气压伤校正OR 1.75(95%CI 1.04-2.96,P=0.04)。

临床怎么用

  • 对多数ARDS患者不推荐常规使用HFOV。
  • 对常规机械通气下严重低氧血症的ARDS患者,可个体化评估HFOV的潜在获益与气压伤风险。

局限性

  • 仅纳入4项随机试验的个体患者数据,样本量有限。
  • 研究间可能存在异质性,聚类效应虽经校正但仍可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: High-frequency oscillatory ventilation (HFOV) is theoretically beneficial for lung protection, but the results of clinical trials are inconsistent, with study-level meta-analyses suggesting no significant effect on mortality. OBJECTIVES: The aim of this individual patient data meta-analysis was to identify acute respiratory distress syndrome (ARDS) patient subgroups with differential outcomes from HFOV. METHODS: After a comprehensive search for trials, two reviewers independently identified randomized trials comparing HFOV with conventional ventilation for adults with ARDS. Prespecified effect modifiers were tested using multivariable hierarchical logistic regression models, adjusting for important prognostic factors and clustering effects. MEASUREMENTS AND MAIN RESULTS: Data from 1,552 patients in four trials were analyzed, applying uniform definitions for study variables and outcomes. Patients had a mean baseline PaO2/FiO2 of 114 ± 39 mm Hg; 40% had severe ARDS (PaO2/FiO2 <100 mm Hg). Mortality at 30 days was 321 of 785 (40.9%) for HFOV patients versus 288 of 767 (37.6%) for control subjects (adjusted odds ratio, 1.17; 95% confidence interval, 0.94-1.46; P = 0.16). This treatment effect varied, however, depending on baseline severity of hypoxemia (P = 0.0003), with harm increasing with PaO2/FiO2 among patients with mild-moderate ARDS, and the possibility of decreased mortality in patients with very severe ARDS. Compliance and body mass index did not modify the treatment effect. HFOV increased barotrauma risk compared with conventional ventilation (adjusted odds ratio, 1.75; 95% confidence interval, 1.04-2.96; P = 0.04). CONCLUSIONS: HFOV increases mortality for most patients with ARDS but may improve survival among patients with severe hypoxemia on conventional mechanical ventilation.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Meade MO, Young D, Hanna S, et al. Severity of Hypoxemia and Effect of High-Frequency Oscillatory Ventilation in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2017. PMID: 28245137. doi:10.1164/rccm.201609-1938OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。